Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyethylene glycol versus lactulose for abdominal pain in children with fecal impaction
IRCT20181214041966N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jun 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Abdominal discomfort and fecal impaction comparing Polyethylene glycol with Lactulose (2 arms). Primary endpoint: Abdominal pain rate. Started Jun 2017; status: completed.
02
Drugs
macrogollactulose
03
Conditions
Abdominal discomfortfecal impaction
Beyond the preview
Go deeper on IRCT20181214041966N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181214041966N1.